尿液中C2C水平对膝关节骨关节炎的诊断价值
Significance of type Ⅱ collagen biomarker C2C in the diagnosis of knee osteoarthritis

DOI: 10.6040/j.issn.1671-7554.0.2014.454

Keywords: Ⅱ型胶原,膝关节骨关节炎,软骨代谢产物,C2C,尿液,
C2C,Urine,Cartilage metabolites,Knee osteoarthritis,Type Ⅱcollagen

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Jordan CD, McWalter EJ, Monu UD, et al. Variability of cubequant T1ρ, quantitative DESS T2, and cones sodium MRI in knee cartilage[J]. Osteoarthritis Cartilage, 2014, 22(10): 1559-1567.
[2]	Ishijima M, Watari T, Naito K, et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis[J]. Arthritis Res Ther, 2011, 13(1): 22.
[3]	Hayashi K, Kim SY, Lansdowne JL, et al. Evaluation of a collagenase generated osteoarthritis biomarker in naturally occurring canine cruciate disease[J]. Veterinary Surgery, 2009, 38(1): 117-121.
[4]	Van Spil WE, DeGroot J, Lems WF, et al. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria[J]. Osteoarthritis Cartilage, 2010, 18(5):605-612.
[5]	Ishijima M, Kaneko H, Kaneko K, et al. The evolving role of biomarkers for osteoarthritis[J]. Ther Adv Musculoskelet Dis, 2014, 6(4): 144-153.
[6]	Attur M, Krasnokutsky-Samuels S, Samuels J, et al. Prognostic biomarkers in osteoarthritis[J]. Curr Opin Rheumatol, 2013, 25(1): 136-144.
[7]	Eyre DR, Oguchi H. The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties and a proposed pathway of formation[J]. Biochem Biophys Res Commun, 1980, 92(2): 403-410.
[8]	Conrozier T, Poole AR, Ferrand F, et al. Serum concentrations of type Ⅱ collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis[J]. Clin Exp Rheumatol, 2008, 26(3): 430-450.
[9]	Bakker MF, Verstappen SM, Welsing PM, et al. The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial[J]. Arthritis Research & Therapy, 2011, 13(3): 70.
[10]	Martín-Millán M, Casta？eda S. Estrogens, Osteoarthritis and inflammation[J]. Joint Bone Spine, 2013, 80(4): 368-373.
[11]	Christgau S, Garnero P, Fledelius C, et al. Collagen type Ⅱ C-telopeptide fragments as an index of cartilage degradation[J]. Bone, 2001, 29(3): 209-215.
[12]	Cibere J, Zhang H, Garnero P, et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study[J]. Arthritis Rheum, 2009, 60(5): 1372-1380.
[13]	Hunter DJ, Nevitt M, Losina E, et al. Biomarkers for osteoarthritis: current position and steps towards further validation[J]. Best Pract Res Clin Rheumatol, 2014, 28(1):61-71.
[14]	Cahue S, Sharma L, Dunlop D, et al. The ratio of type Ⅱ collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis[J]. Osteoarthritis Cartilage, 2007, 15(7): 819-823.
[15]	He G, Chen X, Zhang G, et al. Detection of urine C2C and trace element level in patients with knee osteoarthritis[J]. Cell Biochem Biophys, 2014, 70(1): 475-479.

Full-Text